Use of fluconazole in daily practice: still room for improvement
- PMID: 11481307
- DOI: 10.1093/jac/48.2.303
Use of fluconazole in daily practice: still room for improvement
Abstract
One hundred courses of fluconazole treatment in a university hospital and 81 courses in a non-university teaching hospital have been analysed in a prospective audit to evaluate prescribing practices. The quality of treatments was assessed by an infectious disease specialist and a pharmacist according to standard guidelines. In the non-university hospital, prescribed dosages were lower than in the university hospital, and often below the recommended dose. Mean duration of treatment for oesophageal candidosis and disseminated infections was considerably shorter in the non-university hospital compared with the university hospital, and often judged too short. Microbiological samples were examined in 75% of the cases in both hospitals. The expert reviewers agreed with the indication to use fluconazole in 58-100% of cases in the university hospital and 42-80% in the non-university hospital, depending on the type of infection. There did not appear to be a major problem with inappropriate use of fluconazole. However, important issues for improvement could be identified, such as increasing the dosage and duration of treatment in cases of serious infections, and withholding treatment from patients with colonization rather than infection.
Similar articles
-
Utilization of fluconazole in an intensive care unit at a university hospital in Brazil.Int J Clin Pharm. 2013 Apr;35(2):176-80. doi: 10.1007/s11096-012-9726-z. Epub 2012 Nov 28. Int J Clin Pharm. 2013. PMID: 23187962
-
An audit of the use of antifungal agents.J Antimicrob Chemother. 1996 Jan;37(1):175-85. doi: 10.1093/jac/37.1.175. J Antimicrob Chemother. 1996. PMID: 8647761
-
Use of antifungal therapy in hospitalized patients. II. Results after the marketing of fluconazole.Ann Pharmacother. 1994 Feb;28(2):261-70. doi: 10.1177/106002809402800220. Ann Pharmacother. 1994. PMID: 8173148
-
Fluconazole dose recommendation in urinary tract infection.Ann Pharmacother. 2001 Mar;35(3):369-72. doi: 10.1345/aph.10170. Ann Pharmacother. 2001. PMID: 11261537 Review.
-
Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses.Drugs. 1990 Jun;39(6):877-916. doi: 10.2165/00003495-199039060-00006. Drugs. 1990. PMID: 2196167 Review.
Cited by
-
Duration of antifungal treatment and development of delayed complications in patients with candidaemia.Eur J Clin Microbiol Infect Dis. 2003 Jan;22(1):43-8. doi: 10.1007/s10096-002-0854-6. Epub 2003 Jan 25. Eur J Clin Microbiol Infect Dis. 2003. PMID: 12582743
-
Hospital use of systemic antifungal drugs.BMC Clin Pharmacol. 2005 Feb 10;5:1. doi: 10.1186/1472-6904-5-1. BMC Clin Pharmacol. 2005. PMID: 15703083 Free PMC article.
-
Utilization of fluconazole in an intensive care unit at a university hospital in Brazil.Int J Clin Pharm. 2013 Apr;35(2):176-80. doi: 10.1007/s11096-012-9726-z. Epub 2012 Nov 28. Int J Clin Pharm. 2013. PMID: 23187962
-
Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001.J Clin Microbiol. 2003 Apr;41(4):1440-6. doi: 10.1128/JCM.41.4.1440-1446.2003. J Clin Microbiol. 2003. PMID: 12682127 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical